Publication Author: Knerr_Sarah

• Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system.

  Knerr S, Guo B, Wernli KJ, Mittendorf KF, Feigelson HS, Gilmore MJ, Jarvik GP, Kauffman TL, Keast E, Liles EG, Lynch FL, Muessig KR, Okuyama S, Veenstra DL, Zepp JM, Wilfond BS, Devine B, Goddard KAB. Longitudinal adherence to breast cancer surveillance f

  October 1, 2023

• Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study.

  Guo B, Knerr S, Kauffman TL, Mittendorf KF, Keast E, Gilmore MJ, Feigelson HS, Lynch FL, Muessig KR, Okuyama S, Zepp JM, Veenstra DL, Hsu L, Phipps AI, Lindstrom S, Leo MC, Goddard KAB, Wilfond BS, Devine B; CHARM Study team. Risk management actions follo

  September 1, 2023

• Measuring high-risk parents’ opinions about direct-to-consumer genetic testing for adult-onset inherited cancer syndromes in their adolescent and young adult children.

  Hasser E, Peshkin BN, Hamilton JG, Brower J, Ovadia H, Friedman Ross L, Sacca R, Tarini B, Domchek SM, Vittone S, Sleiman M Jr, Isaacs C, Knerr S, Wilfond BS, Tercyak KP. Measuring high-risk parents’ opinions about direct-to-consumer genetic testing for a

  August 1, 2023

• Cancer genetic testing uptake in the primary care setting: Patient perspectives on barriers and facilitators throughout the testing process.

  Theoryn TN, Beers F, Dusic EJ, Wang C, Cameron D, Harris H, Knerr S, Swisher EM, Trinidad SB. Cancer genetic testing uptake in the primary care setting: Patient perspectives on barriers and facilitators throughout the testing process. J Genet Couns. 2026

  July 9, 2023

• Public Health Genomics: Time to Sharpen the Focus.

  McBride CM, Roberts JS, Knerr S, Guan Y. Public Health Genomics: Time to Sharpen the Focus. Public Health Genomics. 2023;26(1):171-176. doi: 10.1159/000533985. Epub 2023 Sep 20. No abstract available.

  July 9, 2023

• Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer.

  Cheng HH, Sokolova AO, Gulati R, Bowen D, Knerr SA, Klemfuss N, Grivas P, Hsieh A, Lee JK, Schweizer MT, Yezefski T, Zhou A, Yu EY, Nelson PS, Montgomery B. Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer. JCO Precis Oncol.

  January 1, 2023

• Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system.

  Knerr S, Guo B, Mittendorf KF, Feigelson HS, Gilmore MJ, Jarvik GP, Kauffman TL, Keast E, Lynch FL, Muessig KR, Okuyama S, Veenstra DL, Zepp JM, Goddard KAB, Devine B. Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an

  August 15, 2022

• Patient navigation for hereditary colorectal cancer: Design of a randomized controlled trial to determine the effectiveness of pathways to genetic counseling.

  Reed AK, Kohn MJ, Stayman S, Cole AM, Ko CW, Konnick EQ, Swanson PE, Zhang Y, Knerr S. Patient navigation for hereditary colorectal cancer: Design of a randomized controlled trial to determine the effectiveness of pathways to genetic counseling. Contemp C

  May 1, 2022

• Prevalence and prediction of medical distrust in a diverse medical genomic research sample.

  Angelo F, Veenstra D, Knerr S, Devine B. Prevalence and prediction of medical distrust in a diverse medical genomic research sample. Genet Med. 2022 Apr 6. pii: S1098-3600(22)00697-9. doi: 10.1016/j.gim.2022.03.007. [Epub ahead of print]

  April 6, 2022

• Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system.

  Muessig KR, Zepp JM, Keast E, Shuster EE, Reyes AA, Arnold B, Ingphakorn C, Gilmore MJ, Kauffman TL, Hunter JE, Knerr S, Feigelson HS, Goddard KAB. Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an i

  February 10, 2022